News
Early human data in a statement by Eolo Pharma shows it can burn fat even at rest, without appetite suppression or serious ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
(Reuters) - Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival ...
Researchers saw significant increases in testosterone levels for men with obesity or Type 2 diabetes while taking GLP-1 medications, The Hill wrote. Also in the news: vaping, PFAS, junk food, and more ...
GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...
The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows. The YouGov poll, ...
The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
Supplements were also to blame when a 53-year-old woman’s left hand suddenly went numb, according to a case study in the ...
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs. But the drugs can leave some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results